Laia Madrenas
Overview
Explore the profile of Laia Madrenas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
2
Citations
24
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Corominas J, Garriga C, Prenafeta A, Moros A, Canete M, Barreiro A, et al.
Vaccine
. 2025 Jan;
47:126685.
PMID: 39809095
The HIPRA-HH-2 was a multicentre, randomized, active-controlled, double-blind, non-inferiority phase IIb clinical trial comparing the immunogenicity and safety of the PHH-1V adjuvanted recombinant vaccine as a heterologous booster against homologous...
2.
Corominas J, Garriga C, Prenafeta A, Moros A, Canete M, Barreiro A, et al.
Lancet Reg Health Eur
. 2023 May;
28:100613.
PMID: 37131861
Background: A SARS-CoV-2 protein-based heterodimer vaccine, PHH-1V, has been shown to be safe and well-tolerated in healthy young adults in a first-in-human, Phase I/IIa study dose-escalation trial. Here, we report...
3.
Barreiro A, Prenafeta A, Bech-Sabat G, Roca M, Perozo Mur E, March R, et al.
iScience
. 2023 Feb;
26(3):106126.
PMID: 36748086
Current COVID-19 vaccines have been associated with a decline in infection rates, prevention of severe disease, and a decrease in mortality rates. However, SARS-CoV-2 variants are continuously evolving, and development...